Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.46
-0.1300-2.83%
Post-market: 4.43-0.0300-0.67%16:09 EDT
Volume:441.32K
Turnover:1.93M
Market Cap:30.22M
PE:-0.64
High:4.56
Open:4.50
Low:4.04
Close:4.59
Loading ...
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 22, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Jan 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]